Current Drug Targets
Title:Editorial (Thematic Issue: AMPK: New Frontiers in Human Diseases)
Volume: 17 Issue: 8
Author(s): Mario D. Cordero and Benoit Viollet
Affiliation:
Export Options
About this article
Cite this article as:
D. Cordero Mario and Viollet Benoit, Editorial (Thematic Issue: AMPK: New Frontiers in Human Diseases), Current Drug Targets 2016; 17 (8) . https://dx.doi.org/10.2174/1389450117999160321124627
DOI https://dx.doi.org/10.2174/1389450117999160321124627 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Article Metrics
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanoparticulate Drug Delivery Sytem for Cancer Therapy: Oppourtunities and Challenges
Recent Patents on Nanomedicine Importance of Pharmacology Knowledge by Dieticians
Current Nutrition & Food Science Metabolic Syndrome During Menopause
Current Vascular Pharmacology Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile
Current Drug Safety 2,4-Dichloro-5-[(N-aryl/alkyl)sulfamoyl]benzoic Acid Derivatives: In Vitro Antidiabetic Activity, Molecular Modeling and In silico ADMET Screening
Medicinal Chemistry Value of Carnitine Therapy in Kidney Dialysis Patients and Effects on Cardiac Function from Human and Animal Studies
Current Drug Targets Risk Scores for Patients with Chest Pain: Evaluation in the Emergency Department
Current Cardiology Reviews Clinical Proteomics in Cancer Research
Current Proteomics Current Strategies and Drug Targets in the Management of Type 2 Diabetes Mellitus
Current Drug Targets Lipid Lowering Agents, Inflammation and Atherosclerosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry HDL-C Levels and Cardiovascular Disease: More is not Always Better!
Recent Patents on Cardiovascular Drug Discovery Mechanisms of Action and Chemical-Biological Interactions Between Ozone and Body Compartments: A Critical Appraisal of the Different Administration Routes
Current Drug Therapy The Importance of Early Diagnosis and Treatment in Peripheral Arterial Disease: Insights from the PARTNERS and REACH Registries
Current Vascular Pharmacology Calcifediol – More than the Stepchild of CKD-MBD Therapy?
Current Vascular Pharmacology Catheter Ablation of Lone Atrial Fibrillation
Current Pharmaceutical Design COX-2 Inhibitors Celecoxib and Parecoxib: Valuable Options for Postoperative Pain Management
Current Topics in Medicinal Chemistry Obesity-Induced Hypertension: New Insights
Current Pharmaceutical Design MicroRNAs: Biomarkers for Cardiovascular Disease in Patients with Diabetes Mellitus
Current Topics in Medicinal Chemistry Mitochondria: A Novel Therapeutic Target in Diabetic Nephropathy
Current Medicinal Chemistry Pharmacological Strategies Against Glucocorticoid-mediated Brain Damage During Chronic Disorders
Recent Patents on CNS Drug Discovery (Discontinued)